KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,432,003
-11.1%
14,058
-11.9%
0.00%
-20.0%
Q2 2023$1,610,512
+13.0%
15,959
+3.0%
0.01%
+25.0%
Q1 2023$1,425,112
-0.7%
15,490
-2.1%
0.00%0.0%
Q4 2022$1,435,132
+30.9%
15,819
+9.7%
0.00%0.0%
Q3 2022$1,096,000
-15.3%
14,420
-5.8%
0.00%0.0%
Q2 2022$1,294,000
-0.9%
15,305
+2.9%
0.00%
+33.3%
Q1 2022$1,306,000
-1.1%
14,878
-1.4%
0.00%0.0%
Q4 2021$1,320,000
+1.2%
15,090
-5.3%
0.00%0.0%
Q3 2021$1,304,000
-7.8%
15,939
+2.8%
0.00%0.0%
Q2 2021$1,415,000
+5.9%
15,506
-0.8%
0.00%
-25.0%
Q1 2021$1,336,000
-14.1%
15,625
-5.2%
0.00%0.0%
Q4 2020$1,556,000
+5.6%
16,482
-2.8%
0.00%
-20.0%
Q3 2020$1,474,000
+13.2%
16,950
+13.7%
0.01%0.0%
Q2 2020$1,302,000
-17.8%
14,903
-22.4%
0.01%
-44.4%
Q1 2020$1,583,000
-24.9%
19,203
-13.7%
0.01%
-10.0%
Q4 2019$2,108,000
+9.4%
22,264
+0.5%
0.01%0.0%
Q3 2019$1,926,000
-27.0%
22,160
-23.3%
0.01%
-28.6%
Q2 2019$2,638,000
+4.4%
28,888
+10.0%
0.01%0.0%
Q1 2019$2,526,000
-1.2%
26,273
-11.8%
0.01%
-22.2%
Q4 2018$2,556,000
-7.2%
29,788
-6.8%
0.02%
+12.5%
Q3 2018$2,754,000
+15.4%
31,968
+1.2%
0.02%
+6.7%
Q2 2018$2,387,000
-11.2%
31,603
-5.0%
0.02%
-25.0%
Q1 2018$2,689,000
+7.6%
33,262
+11.8%
0.02%0.0%
Q4 2017$2,498,000
+3.7%
29,750
+6.0%
0.02%
-9.1%
Q3 2017$2,409,000
+2.9%
28,065
+0.1%
0.02%
-4.3%
Q2 2017$2,340,000
+12.4%
28,035
+0.1%
0.02%0.0%
Q1 2017$2,081,000
+8.0%
28,014
+5.9%
0.02%0.0%
Q4 2016$1,927,000
-12.9%
26,458
-5.6%
0.02%
-17.9%
Q3 2016$2,213,000
-3.7%
28,028
+0.6%
0.03%
-20.0%
Q2 2016$2,298,000
+50.5%
27,851
+32.2%
0.04%
+40.0%
Q1 2016$1,527,000
-38.9%
21,075
-27.4%
0.02%
-39.0%
Q4 2015$2,499,000
-17.2%
29,045
-11.5%
0.04%
-19.6%
Q3 2015$3,018,000
-22.0%
32,835
-16.6%
0.05%
-15.0%
Q2 2015$3,871,000
+4.1%
39,362
+4.4%
0.06%
+5.3%
Q1 2015$3,719,000
-5.8%
37,717
-11.4%
0.06%
-13.6%
Q4 2014$3,946,000
+1.8%
42,581
+3.4%
0.07%
-4.3%
Q3 2014$3,876,000
-76.8%
41,175
-77.7%
0.07%
-75.7%
Q2 2014$16,682,000
+8.6%
184,269
+2.0%
0.28%
+5.6%
Q1 2014$15,362,000
+6.7%
180,687
+0.9%
0.27%
+11.6%
Q4 2013$14,394,000
+8.5%
179,071
+3.6%
0.24%
-3.2%
Q3 2013$13,265,000
+8.5%
172,923
-0.0%
0.25%
+0.4%
Q2 2013$12,231,000172,9710.25%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders